Page last updated: 2024-11-10

eptazocine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

eptazocine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3042090
CHEMBL ID70566
CHEBI ID134944
SCHEMBL ID25862
MeSH IDM0104576

Synonyms (26)

Synonym
sedapain
eptazocine
CHEBI:134944
CHEMBL70566
72522-13-5
D07904
eptazocine (inn)
2208zli77s ,
unii-2208zli77s
(-)-(1s,6s)-2,3,4,5,6,7-hexahydro-1,4-dimethyl-1,6-methano-1h-4-benzazonin-10-ol
eptazocina [inn-spanish]
eptazocina
eptazocinum
eptazocine [inn]
1,6-methano-1h-4-benzazonin-10-ol, 2,3,4,5,6,7-hexahydro-1,4-dimethyl-, (1s)-
eptazocinum [inn-latin]
SCHEMBL25862
eptazocine [mi]
eptazocine [who-dd]
4517B
(1s,6s)-1,4-dimethyl-2,3,4,5,6,7-hexahydro-1h-1,6-methanobenzo[e]azonin-10-ol
Q5384037
(1s,9s)-1,11-dimethyl-11-azatricyclo[7.4.1.02,7]tetradeca-2(7),3,5-trien-4-ol
CS-0026069
HY-106568
DTXSID501024513

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tetralinsCompounds containing a tetralin skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (58.82)18.7374
1990's5 (29.41)18.2507
2000's1 (5.88)29.6817
2010's1 (5.88)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.59 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.24 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]